Diethyldithiocarbamate causes nigral cell loss and dopamine depletion with nontoxic doses of MPTP

Experimental Neurology

Volumn 156, Issue 1, 1999, Pages 62-70

  Walters, Tessa L ^a,b   Irwin, Ian ^b   Delfani, Kioumars ^a   Langston, J William ^b   Janson, Ann Marie ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b PARKINSON S INSTITUTE   (United States)

Author keywords

1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Immunohistochemistry; Mouse; Optical fractionator; Stereology; Striatum; Substantia nigra; Tyrosine hydroxylase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DIETHYLDITHIOCARBAMIC ACID; DOPAMINE; TYROSINE 3 MONOOXYGENASE;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL LOSS; DOPAMINERGIC NERVE CELL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; STEREOLOGY; SUBSTANTIA NIGRA;

EID: 0033062725     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6997     Document Type: Article

References (41)

1. Bachurin S. O., Shevtzova E. P., Lermontova N. N., Serkova T. P., Ramsay R. R. The effect of dithiocarbamates on neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and on mitochondrial respiration chain. Neurotoxicology. 17:1996;897-904.
2. Beinert H. Copper in biological systems: A report from the 6th Manziana Conference, September 23-27, 1990. J. Inorg. Biochem. 44:1991;173-218.
3. Burns R. S., Chiueh C. C., Markey S. P., Ebert M. H., Jacobowitz D. M., Kopin I. J. A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra byN. Proc. Natl. Acad. Sci. USA. 80:1983;4546-4550.
4. Chan P., Di Monte D. A., Langston J. W., Janson A. M. (+)MK-801 does not prevent MPTP-induced loss of nigral neurons in mice. J. Pharmacol. Exp. Ther. 280:1997;439-446.
5. Chan P., Zhao M., Di Monte D. A., Langston J. W., Janson A. M. Methamphetamine with or without 2-deoxyglucose does not cause loss of dopamine neurons in the substantia nigra as evaluated with an unbiased stereological method. Soc. Neurosci. Abstr. 22:1997;2076.
6. Chiba K., Trevor A. J., Castagnoli N. Jr. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem. Biophys. Res. Commun. 120:1984;574-578.
7. Corsini G. U., Pintus S., Chiueh C. C., Weiss J. F., Kopin I. J. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate. Eur. J. Pharmacol. 119:1985;127-128.
8. Deitrich R. A., Erwin V. G. Mechanism of the inhibition of aldehyde dehydrogenase in vivo by disulfiram and diethyldithiocarbamate. Mol. Pharmacol. 7:1971;301-307.
9. Ferraz H. B., Bertolucci P. H., Pereira J. S., Lima J. G., Andrade L. A. Chronic exposure to the fungicide maneb may produce symptoms and signs of CNS manganese intoxication. Neurology. 38:1988;550-553.
10. Franklin K. B. J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates. 1997;Academic Press, London.
11. Gotz M. E., Dirr A., Burger R., Janetsky B., Weinmuller M., Chan W. W., Chen S. C., Reichmann H., Rausch W. D., Riederer P. Effect of lipoic acid on redox state of coenzyme Q in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and diethyldithiocarbamate. Eur. J. Pharmacol. 266:1994;291-300.
12. Gundersen H. J. G. Stereology of arbitrary particles. J. Microsc. 143:1986;3-45.
13. Gundersen H. J. G., Bagger P., Bendtsen T. F., Evans S. M., Korbo L., Marcussen N., Møller A., Nielsen K., Nyengaard J. R., Pakkenberg B., Sørensen F. B., Vesterby A., West M. J. The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS. 96:1988;857-881.
14. Hanawa S., Marsushita M. An autopsy case of disulfiram induced psychosis with Parkinsonian syndrome. Seishin Shinkeigaku Zasshi. 84:1982;503-512.
15. Heikkila R. E., Cabbat F. S., Cohen G. In vivo inhibition of superoxide dismutase in mice by diethyldithiocarbamate. J. Biol. Chem. 251:1976;2182-2185.
16. Heikkila R. E., Hess A., Duvoisin R. C. Dopamine neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Science. 224:1984;1451-1453.
17. Hoogenrad T. U. Dithiocarbamates and Parkinson's disease. Lancet. 1:1988;767.
18. Hyland R., Gescher A., Thummel K., Schiller C., Jheeta P., Mynett K., Smith A. W., Mraz J. Metabolic oxidation and toxification ofN. Mol. Pharmacol. 41:1992;259-266.
19. Irwin I., Langston J. W. Endogenous toxins as potential etiologic agents in Parkinson's disease. Etiology of Parkinson's Disease. 1995;Dekker, New York. p. 153-201.
20. Irwin I., Langston J. W. Mechanism of cell death. Ellenberg J. H., Koller W. C., Langston J. W. Etiology of Parkinson's Disease. 1995;97-113 Dekker, New York.
21. Irwin I., Wu E. Y., DeLanney L. E., Trevor A., Langston J. W. The effect of diethyldithiocarbamate on the biodisposition of MPTP: An explanation for enhanced neurotoxicity. Eur. J. Pharmacol. 141:1987;209-217.
22. Jain A., Martensson J., Stole E., Auld P., Meister A. Glutathione deficiency leads to mitochondrial damage in brain. Proc. Natl. Acad. Sci. USA. 88:1991;1913-1917.
23. Janson A. M. Neuronal cell death by apoptosisin vivo. Soc. Neurosci. Abstr. 22:1996;721.
24. Janson A. M., Fuxe K., Agnati L. F., Kitayama I., Harfstrand A., Andersson K., Goldstein M. Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection. Brain Res. 455:1988;332-345.
25. Janson A. M., Møller A. Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemitransection: An analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat. Neuroscience. 57:1993;931-941.
26. Javitch J. A., D'Amato R. J., Strittmatter S. M., Snyder S. H. Parkinsonism-inducing neurotoxin,NN. Proc. Natl. Acad. Sci. USA. 82:1985;2173-2177.
27. Krauss J. K., Mohadjer M., Wakhloo A. K., Mundinger F. Dystonia and akinesia due to pallidoputaminal lesions after disulfiram intoxication. Mov. Disord. 6:1991;166-170.
28. Langston J. W., Ballard P. A., Tetrud J. W., Irwin I. Chronic parkinsonism in humans due to a product of meperidine analog synthesis. Science. 219:1983;979-980.
29. Laplane D., Attal N., Sauron B., de Billy A., Dubois B. Lesions of basal ganglia due to disulfiram neurotoxicity. J. Neurol. Neurosurg. Psych. 55:1992;925-929.
30. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-273.
31. Meco G., Alessandria A., Bonifati V., Giustini P. Risperidone for hallucinations in levodopa-treated Parkinson's disease patients. Lancet. 343:1994;1370-1371.
32. Miller D. B., Reinhard J. F. Jr., Daniels A. J., O'Callaghan J. P. Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and in vitro 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridinium. J. Neurochemistry. 57:1991;541-549.
33. Nicklas W. J., Vyas I., Heikkila R. E. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Life Sci. 36:1985;2503-2508.
34. Przedborski S., Kostic V., Jackson-Lewis V., Naini A. B., Simonetti S., Fahn S., Carlson E., Epstein C. J., Cadet J. L. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J. Neurosci. 12:1992;1658-1667.
35. Ramsay R. R., Singer T. P. Energy-dependent uptake ofN. J. Biol. Chem. 261:1986;7585-7587.
36. Ricaurte G. A., Langston J. W., Delanney L. E., Irwin I., Peroutka S. J., Forno L. S. Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A neurochemical and morphological reassessment. Brain Res. 376:1986;117-124.
37. Sunderman F. W. Therapeutic properties of sodium diethyldithiocarbamate: Its role as an inhibitor in the progression of AIDS. Ann. Clin. Lab. Sci. 21:1991;70-81.
38. Vaglini F., Fascetti F., Fornai F., Maggio R., Corsini G. U. (+)MK-801 prevents the DDC-induced enhancement of MPTP toxicity in mice. Brain Res. 668:1994;194-203.
39. West M., Slomianka L., Gundersen H. J. G. Unbiased stereological estimation of the total number of neurons in the subdivisions of rat hippocampus using the optical fractionator. Anatom. Rec. 231:1991;482-497.
40. Yurek D., Deutch A., Roth R., Sladek J. Jr. Morphological, neurochemical, and behavioral characterizations associated with the combined treatment of diethyldithiocarbamate and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Brain Res. 497:1989;250-259.
41. Zuddas A., Vaglini F., Fornai F., Corsini G. U. Selective lesion of the nigrostriatal dopaminergic pathway by MPTP and acetylaldehyde or diethyldithiocarbamate. Neurochem. Int. 20. 1992;287S-293S.